Skip to main content

Table 2 Plaque characteristics

From: Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography

 

Overall (n =166)

Tertile 1 (MAGE <49.1) (n =55)

Tertile 2 (49.1 ≤ MAGE <85.3) (n = 50)

Tertile 3 (85.3 ≤ MAGE) (n =61)

P value

Culprit lesion

64 (38.6)

20 (36.4)

21 (42.0)

23 (37.7)

0.83

Lipid-rich plaque

91 (54.8)

22 (40.0)

31 (62.0)

38 (62.3)

0.026

Lipid length (mm)

16.1 ± 6.7

13.2 ± 5.0

15.0 ± 6.2

19.5 ± 7.1

<0.001

Mean lipid arc

183.1 ± 51.9

147.1 ± 37.2

173.5 ± 43.7

223.4 ± 41.0

<0.001

Calcification

84 (50.6)

25 (45.4)

29 (58.0)

30 (49.2)

0.42

Calcification length (mm)

5.3 ± 3.8

5.6 ± 3.7

4.3 ± 2.7

6.1 ± 4.6

0.21

Mean calcification arc

119.6 ± 71.3

125.8 ± 73.0

90.5 ± 42.6

141.7 ± 83.2

0.019

TCFA

37 (22.3)

4 (7.3)

9 (18.0)

24 (39.3)

<0.001

Microchannel

99 (59.6)

23 (41.8)

29 (58.0)

47 (77.0)

0.001

Thrombus

13 (7.8)

1 (1.8)

5 (10.0)

7 (11.5)

0.12

Plaque location

    

0.79

RCA

 Proximal

28 (16.9)

8 (14.5)

9 (18.0)

11 (18.0)

 

 Mid

12 (7.2)

5 (9.1)

3 (6.0)

4 (6.6)

 

 Distal

8 (4.8)

1 (1.8)

5 (10.0)

2 (3.3)

 

LAD

 Proximal

34 (20.5)

11 (20.0)

9 (18.0)

14 (22.9)

 

 Mid

27 (16.2)

8 (14.5)

10 (20.0)

9 (14.7)

 

 Distal

10 (6.0)

4 (7.3)

4 (8.0)

2 (3.3)

 

LCx

 Proximal

13 (7.8)

7 (12.7)

1 (2.0)

5 (8.2)

 

 Mid

26 (15.7)

8 (14.5)

7 (14.0)

11 (18.0)

 

 Distal

8 (4.8)

3 (5.5)

2 (4.0)

3 (4.9)

 
  1. Values are mean ± SD or no. (%) LAD: left anterior descending artery; LCx: left circumflex artery; RCA: right coronary artery; TCFA: thin-cap fibroatheroma